How do oral pathogenic bacteria potentially contribute to inflammatory processes in autoimmune liver disease? Results from a systematic review

Current evidence supports an association between oral microbiota dysbiosis and inflammatory mechanisms. Although causality cannot be established, the oral-gut-liver axis may represent a promising source of biomarkers and therapeutic targets.